Joel Papernik is a corporate and mergers and acquisitions attorney at Mintz who is esteemed for his work on life sciences deals. He concentrates on corporate, commercial, securities, corporate governance, and mergers and acquisitions matters as well as strategic transactions and corporate structuring. Joel leads acquisitions and sales of public and private companies and assists all types of companies with the intricate processes of offloading enterprises, divisions, and subsidiaries. His capabilities include managing collaborative arrangements, licensing transactions, and other strategic deals for life sciences companies and helping overseas firms set up operations and make acquisitions in the United States. He also serves as counsel to boards of directors and special committees. He is a member of the firm’s Opinions Committee and a former member of the firm’s Policy Committee. Joel moderated the panel titled “Utilizing an Existing SPAC To Take Your Private Biotech Company Public” at the 2022 BIO International Convention. This panel covered what the next few years hold in store for SPACs looking to complete a merger and for those who have merged with private biotech companies.